Diane Dorier-Sammut

Gene Therapy: a technology that is revolutionizing the pharmaceutical market Diane Dorier-Sammut

The pharmaceutical world has changed considerably in recent years with the growth of the biotechnology industry. Following the discovery of DNA decoding, techniques have been developed to create new DNA-based drugs called gene therapies. These advanced therapies would not only cure symptoms as traditional medicines do, but would treat at the source: the gene. The gene therapy startups would then like to convince venture capital companies on the one hand, and "Big Pharma" on the other hand, to collaborate with them. Big Pharma is becoming increasingly curious about this area and has moved from an independent, mass-market-oriented business model to a collaborative model focused on niche markets. The genomic revolution has begun, raising new economic, regulatory and ethical questions. The example of the Boston-based LogicBio Therapeutics company illustrates the strategic issues currently facing startups in the field.